Morgan Stanley analyst Tejas Savant raised the firm’s price target on Thermo Fisher to $670 from $613 and keeps an Overweight rating on the shares following the company’s "solid" top and bottom line beat in Q4 and initial FY23 outlook that topped the Street view. The 7% core growth outlook is "solid" and "sufficient to calm investor nerves," said the analyst, who reiterates Thermo Fisher as a top pick.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher price target lowered to $693 from $710 at Baird
- Thermo Fisher price target raised to $660 from $630 at Barclays
- Thermo Fisher price target raised to $700 from $650 at Citi
- Thermo Fisher Scientific Earnings Report: Is it a Beat?
- Thermo Fisher CEO: Very excited about potential growth in China in 2023